🤫 Unfair Advantage: 10 bargain stocks found using this simple toolSee undervalued stocks

US judge blocks FDA graphic warning label requirement for cigarettes

Published 01/14/2025, 12:44 PM
Updated 01/14/2025, 01:10 PM
© Reuters. FILE PHOTO: A man smokes a cigarette while sitting in the Times Square section of New York City, U.S., January 18, 2023. REUTERS/Shannon Stapleton/File Photo

© Reuters. FILE PHOTO: A man smokes a cigarette while sitting in the Times Square section of New York City, U.S., January 18, 2023. REUTERS/Shannon Stapleton/File Photo

VGR
0.00%
BTI
1.14%
IMBBY
-0.31%

By Nate Raymond (NS:RYMD)

(Reuters) - A federal judge in Texas has blocked the U.S. Food and Drug Administration from enforcing a looming requirement that cigarette packages and advertisements contain graphic warnings illustrating the health risks of smoking.

U.S. District Judge J. Campbell Barker in Tyler, Texas, on Monday sided with R.J. Reynolds and other tobacco companies in finding the FDA went beyond its authority by requiring packaging and advertising to contain 11 specific warnings.

He said those warnings go above and beyond the nine that Congress specified when in 2009 it passed the Tobacco Control Act, which gave the FDA the authority to regulate tobacco products and mandated adoption of the graphic warnings.

Barker, who was appointed by Republican President-elect Donald Trump during his first term in the White House, said not only did the FDA adopt two extra warnings beyond the nine the law required, but it only used the exact text Congress required for two of the remaining nine.

The 11 graphic warnings include depictions of how smoking can cause bladder, head and neck cancer; fatal lung disease; stunted fetal growth during pregnancy; cataracts; and type 2 diabetes.

The FDA argued the law gave it the authority to adjust the format, type and text of any of the required labels. But Barker said that power was limited, noting that even if the FDA was allowed to rewrite the nine warnings, it could not add two extra ones.

"Courts are not free to second-guess policy decisions expressed in the plain text of the congressional enactments," Barker wrote.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads.

The judge delayed the rule's effective date pending further litigation, preventing the FDA from proceeding to enforce it starting in February 2026.

The ruling was a victory for R.J. Reynolds, which is part of British American Tobacco (NYSE:BTI) and had sued in 2020 alongside Imperial Brands (OTC:IMBBY)' subsidiary ITG Brands and Vector Group (NYSE:VGR)'s Liggett Group unit.

R.J. Reynolds and the FDA declined to comment.

The decision marked the second time Barker has blocked the FDA's warning label rule. In 2022, the judge concluded the requirement violated the companies' speech rights under the U.S. Constitution's First Amendment.

The New Orleans-based 5th U.S. Circuit Court of Appeals reversed that decision in March, and the U.S. Supreme Court in November declined to hear the tobacco companies' appeal. But the companies had asserted other, non-constitutional arguments that Barker needed to rule on.

Should you invest $2,000 in VGR right now?

ProPicks AI are 6 model portfolios created by Investing.com which identify the best stocks for investors to buy now. The stocks that made the cut could produce monster returns in the coming years. Is VGR one of them?

Unlock ProPicks AI to find out

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.